Delivery Order SPE2DB22D3501-SPE2DB24FTZ59

Award Date 12/28/23
Potential Completion Date 12/29/23
Potential Value $30K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $99,951.13 and covers the delivery of pharmaceutical products, including the drug Sprycel 100mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award, with ID SPE2DB22D1017|SPE2DB23FF5XA, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $9,746.29 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100mg Tablet 30s. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,948.33, is a Firm Fixed Price Delivery Order for the supply of Sprycel 100 mg tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a Firm Fixed Price delivery order for the pharmaceutical product Sprycel 140 mg tablets, with a ceiling value of $12,028.56 and a performance period through April 1, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,506.62 firm fixed-price delivery order is for the supply of the medication Sprycel 100 mg tablets, with a completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including SPRYCEL 70 MG TABLET 60S, valued at $19,604.43. The contract is a delivery order with a firm fixed price, with an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The firm fixed price delivery order, valued at $5,386.02, is for the supply of Sprycel 70 mg tablets. This award was not set aside for a specific business category. AmerisourceBergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,685.10 firm-fixed-price delivery order contract is for the supply of the drug Sprycel (dasatinib) 50 mg tablets. The contract has an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTZ59
    Delivery Order

This federal contract award is for delivery order SPE2DB24FTZ59 issued under an existing $999,999,999 Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor, Amerisourcebergen Drug Corp. The contract is for the supply of pharmaceutical products, including Sprycel 100 mg tablets, to support military healthcare programs. The award has a ceiling value of $29,974.49 and an ultimate completion date of December 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution firm that has a long-standing relationship with the DLA for providing essential medical commodities to the Department of Defense and Veterans Affairs healthcare systems. This contract award was made through full and open competition, with no set-aside designation.

Generated 5/13/25, 9:44 AM